IL243432A0 - Synthetic oligosaccharides for vaccination against p. aeruginosa and uses thereof - Google Patents

Synthetic oligosaccharides for vaccination against p. aeruginosa and uses thereof

Info

Publication number
IL243432A0
IL243432A0 IL243432A IL24343215A IL243432A0 IL 243432 A0 IL243432 A0 IL 243432A0 IL 243432 A IL243432 A IL 243432A IL 24343215 A IL24343215 A IL 24343215A IL 243432 A0 IL243432 A0 IL 243432A0
Authority
IL
Israel
Prior art keywords
synthetic oligosaccharides
aeruginosa vaccine
aeruginosa
vaccine
oligosaccharides
Prior art date
Application number
IL243432A
Other languages
English (en)
Hebrew (he)
Original Assignee
Synglyco Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synglyco Pharmaceuticals Inc filed Critical Synglyco Pharmaceuticals Inc
Publication of IL243432A0 publication Critical patent/IL243432A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL243432A 2013-07-03 2015-12-31 Synthetic oligosaccharides for vaccination against p. aeruginosa and uses thereof IL243432A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361842474P 2013-07-03 2013-07-03
PCT/US2014/045057 WO2015002954A1 (en) 2013-07-03 2014-07-01 Synthetic oligosaccharides for p. aeruginosa vaccine

Publications (1)

Publication Number Publication Date
IL243432A0 true IL243432A0 (en) 2016-03-31

Family

ID=52144159

Family Applications (1)

Application Number Title Priority Date Filing Date
IL243432A IL243432A0 (en) 2013-07-03 2015-12-31 Synthetic oligosaccharides for vaccination against p. aeruginosa and uses thereof

Country Status (13)

Country Link
US (1) US20160144016A1 (enExample)
EP (1) EP3016685B1 (enExample)
JP (1) JP2016525507A (enExample)
KR (1) KR20160098161A (enExample)
CN (1) CN105517573A (enExample)
AU (1) AU2014284457A1 (enExample)
CA (1) CA2917192A1 (enExample)
CL (1) CL2015003792A1 (enExample)
HK (1) HK1217642A1 (enExample)
IL (1) IL243432A0 (enExample)
MX (1) MX2016000195A (enExample)
SG (1) SG11201510792XA (enExample)
WO (1) WO2015002954A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016138164A1 (en) * 2015-02-26 2016-09-01 Thevax Genetics Vaccine Co., Ltd. A vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific t-cell responses
CN107827981B (zh) * 2017-11-01 2019-10-25 深圳市国创纳米抗体技术有限公司 抗绿脓杆菌外毒素a的纳米抗体及其应用
CA3160266A1 (en) * 2019-12-04 2021-06-10 University Of Montana Antibacterial carbohydrate vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693891A (en) * 1985-09-09 1987-09-15 Miles Laboratories, Inc. Vaccine for Pseudomonas aeruginosa
ATE458006T1 (de) * 2003-05-14 2010-03-15 Kenta Biotech Ag Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa
CN101912609B (zh) * 2009-08-20 2012-02-01 成都蓉生药业有限责任公司 防治绿脓杆菌感染的组合物及其制备方法
CA2797052A1 (en) * 2010-04-23 2011-10-27 Ancora Pharmaceuticals Inc. Synthetic oligosaccharides for staphyloccocus vaccine
CN101947323B (zh) * 2010-07-26 2013-02-27 北京绿竹生物制药有限公司 一种革兰氏阴性细菌疫苗及其制备方法
WO2012082635A1 (en) * 2010-12-13 2012-06-21 Ancora Pharmaceuticals, Inc. Synthetic oligosaccharide group a streptococcus
EP2554549A1 (en) * 2011-08-02 2013-02-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools
EP2884842A4 (en) * 2012-07-16 2016-04-20 Visterra Inc SYNTHETIC OLIGOSACCHARIDES FOR ANTI-P. aeruginosa

Also Published As

Publication number Publication date
CA2917192A1 (en) 2015-01-08
AU2014284457A1 (en) 2016-01-28
HK1217642A1 (zh) 2017-01-20
SG11201510792XA (en) 2016-01-28
CL2015003792A1 (es) 2017-01-20
EP3016685A4 (en) 2016-11-23
KR20160098161A (ko) 2016-08-18
MX2016000195A (es) 2016-08-18
CN105517573A (zh) 2016-04-20
EP3016685B1 (en) 2018-01-31
US20160144016A1 (en) 2016-05-26
JP2016525507A (ja) 2016-08-25
WO2015002954A1 (en) 2015-01-08
EP3016685A1 (en) 2016-05-11

Similar Documents

Publication Publication Date Title
IL276210B1 (en) Mers-cov vaccine
EP3074073A4 (en) Medicament device
HUE038899T2 (hu) Gyógyszer kombináció
EP3059363A4 (en) Locking device
PL2976355T3 (pl) Szczepionki przeciwko Chlamydia sp.
EP2960770A4 (en) Device
GB201301085D0 (en) Glycoconjugate Vaccine
TWI561543B (en) Multy-block copolymer
GB201411896D0 (en) .
GB201302863D0 (en) The Instaponytail
PL2958935T3 (pl) Szczepionka
SG11201510792XA (en) Synthetic oligosaccharides for p. aeruginosa vaccine
EP3048313A4 (en) Component-securing device
EP2884842A4 (en) SYNTHETIC OLIGOSACCHARIDES FOR ANTI-P. aeruginosa
EP3012016A4 (en) Powder-processing device
EP3029701A4 (en) Switch-operation-determining device
GB2519519B (en) Stop
AU5329P (en) USCAL83901 Calibrachoa hybrid
AU5328P (en) USCAL08501 Calibrachoa hybrid
GB201409791D0 (en) .
GB201316662D0 (en) Pharmaceutical Combination
GB201320739D0 (en) The fold-a-way
GB201322661D0 (en) .
GB201319475D0 (en) The wiperactive
GB201317585D0 (en) The dehydrometer